Plus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline

Press/Media: Press / Media

PeriodMar 30 2020

Media coverage

19

Media coverage

  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletTheStreet.com
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletMorningstar.com
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletForex TV
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletMarketScreener.com
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletStockwatch
    CountryCanada
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletMarket Newsdesk
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletTradingCharts.com
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletCrwe World
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletWVB
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletIndia Pharma News
    CountryIndia
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletJotup
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletFirstWord Pharma
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletBiotechgate
    CountrySwitzerland
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletGlobeNewswire
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletEIN Presswire
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
    Media name/outletPrimeNewswire (Top News)
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitleLicenses Novel Oncology Platform, Expands Pipeline
    Media name/outletMarket News Publishing
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • Title07:45 EDT Plus Therapeutics licenses oncology platform, expands pipeline
    Media name/outletTheflyonthewall.com
    CountryUnited States
    Date3/30/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Licenses Novel Oncology Platform Expands Pipeline
    Media name/outletBioPortfolio
    CountryUnited Kingdom
    Date3/30/20
    PersonsAndrew Brenner